BFM
IMGN

Boothbay Fund Management’s Immunogen Inc IMGN Stock Holding History

Boothbay Fund Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-104,200
Closed -$3.09M – 2055
2023
Q4 		$3.09M Sell
104,200
-982,500
-90% -$19.6M 0.08% 351
2023
Q3 		$17.2M Buy
1,086,700
+425,100
+64% +$7.07M 0.41% 31
2023
Q2 		$12.5M Buy
661,600
+640,300
+3,006% +$7.56M 0.27% 48
2023
Q1 		$81.8K Sell
21,300
-121,200
-85% -$517K ﹤0.01% 1977
2022
Q4 		$707K Buy
+142,500
New +$773K 0.02% 1042
2021
Q4 		– Sell
-447,000
Closed -$2.53M – 2314
2021
Q3 		$2.53M Buy
+447,000
New +$2.58M 0.07% 362
2019
Q1 		– Sell
-601
Closed -$288K – 915
2018
Q4 		$288K Buy
+601
New +$3.65K 0.04% 394

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Boothbay Fund Management's IMGN Position: Q1 2024 in Review

Boothbay Fund Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 70,394 shares — an estimated $2.09M sold.

Boothbay Fund Management first reported a position in IMGN in Q1 2019 and held it in 7 quarters. The position peaked at $2.09M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Boothbay Fund Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 70,394 Immunogen Inc shares in Q1 2024, an estimated $2.09M.
  • Boothbay Fund Management first reported a position in Immunogen Inc in Q1 2019 and held it in 7 quarters.
  • Boothbay Fund Management's Immunogen Inc position peaked at $2.09M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Boothbay Fund Management's 13F filing for Q1 2024, filed 15 May 2024.